Expert NetworkExpert InterviewTVTX

Slingshot members are talking to an expert! The topic is:

Discussing Travere Therapeutics Announcement of Full FDA Approval of FILSPARI (sparsentan) for FSGS

Executed on:Apr 29, 2026 10:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution:  Mass General | Harvard
  • Clinical researcher & clinician in academic nephrology practice; Nephrologist at  Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School.
  • Currently manages 30+ patients each for IgAN and FSGS
  • Conducts patient-oriented research in the areas of calciphylaxis, vascular calcification and hyponatremia, has authored over 50 peer-reviewed research articles, and research is funded by organizations including the American Kidney Fund & the National Kidney Foundation.

Interview Goal

The goal of this interview with a nephrologist is to discuss the FDA approval of Travere Therapeutics' FILSPARI and its implications for the FSGS treatment landscape. 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.